ANAPTYSBIO INC (8) | Business Operations (2)
- Amendment No. 3 to the Collaboration and Exclusive License Agreement (Filed With SEC on February 25, 2021)
- Confidential Settlement and Modification Agreement dated as of October 23, 2020 (Filed With SEC on February 25, 2021)
